RecruitingNCT06983366

Validation and Clinical Utility of the Lung Sliding Index (LSI) for Differentiating Pulmonary Diseases

Validation and Clinical Utility of the Lung Sliding Index (LSI) for Differentiating Pulmonary Diseases: A Prospective Case-Control Study

Sponsor

Assiut University

Enrollment

700 participants

Start Date

May 30, 2025

Study Type

OBSERVATIONAL

Conditions

Pneumothorax COPD Pneumonia Bronchiectasis ILD Pleural Effusion Disorder Pulmonary Oedema

Summary

This upcoming case-control study aims to confirm the Lung Sliding Index (LSI), a new ultrasound score that measures how well the pleura moves, in various lung diseases. The study will check how well the LSI can tell apart different lung diseases (like pneumothorax, interstitial lung disease, COPD, pneumonia, and pulmonary edema), how it relates to signs of disease severity, and how consistent the results are between different operators who have received the same training. Secondary objectives include assessing patient and operator satisfaction and feasibility using validated Likert scales.

Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This study is testing and validating a new ultrasound measurement called the Lung Sliding Index (LSI) to help doctors quickly and accurately tell apart different types of lung diseases using bedside ultrasound. Unlike X-rays or CT scans, lung ultrasound is fast, radiation-free, and portable. **You may be eligible if...** - You are 18 or older - You have been diagnosed with one of the lung conditions being studied (or are a healthy person for comparison) - You are able to provide written consent **You may NOT be eligible if...** - You cannot tolerate or undergo a lung ultrasound - You have significant chest wall abnormalities that prevent proper scanning - You are on a mechanical ventilator - More than 2 lung zones cannot be scanned adequately Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.